Transcriptomics

Dataset Information

0

DALIA-1 Whole Blood Longitudinal Gene Expression


ABSTRACT: The DALIA-1 trial was designed to evaluate the safety and immunogenicity of a DC-based vaccine generated by culturing blood monocytes with GM-CSF and IFN-a. DCs were pulsed for 24 hrs with the ANRS LIPO5 peptide pool and activated for the last 6 hrs with LPS. In total, 19 asymptomatic HAART-treated patients were included in the study. Microarray samples were collected in both the treatment phase and follow-up phase of the study.

ORGANISM(S): Homo sapiens

PROVIDER: GSE46734 | GEO | 2015/05/22

SECONDARY ACCESSION(S): PRJNA202208

REPOSITORIES: GEO

Similar Datasets

2015-05-22 | E-GEOD-46734 | biostudies-arrayexpress
2024-01-01 | E-MTAB-12922 | biostudies-arrayexpress
2012-03-01 | E-GEOD-31725 | biostudies-arrayexpress
2023-12-30 | GSE102574 | GEO
2022-01-12 | GSE125019 | GEO
2014-09-30 | E-GEOD-61835 | biostudies-arrayexpress
2006-07-04 | GSE5220 | GEO
2019-02-22 | GSE121185 | GEO
2012-03-01 | GSE31725 | GEO
2005-06-17 | GSE2713 | GEO